Netherlands Wound Care Management Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The netherlands wound care management devices market size was valued at USD 220.46 million in 2025 and estimated to grow from USD 231.24 million in 2026 to reach USD 293.62 million by 2031, at a CAGR of 4.89% during the forecast period (2026-2031). This report is Segmented by Product (Wound Care [Dressings, Wound-Care Devices, and More] and Wound Closure [Sutures, Surgical Staplers, and More]), Wound Type (Chronic Wounds and Acute Wounds), End User (Hospitals & Specialty Wound Clinics and More), and Mode of Purchase (Institutional Procurement and Retail / OTC Channel). The Market and Forecasts are Provided in Terms of Value (USD).

Netherlands Wound Care Management Devices Market Trends and Insights

Growing incidence of chronic wounds & diabetic ulcers

Lower diabetic-foot-ulcer incidence of 0.34% among Dutch diabetes patients coexists with a growing elderly population whose frailty pushes chronic wound numbers upward. Pressure ulcers affect 4.2% of nursing-home residents, with more than one-fifth infected, sustaining demand for antimicrobial dressings. Multidisciplinary centers achieve 69% closure rates for recurrent diabetic ulcers within 75 days, extending ulcer-free periods beyond 350 days through reconstructive surgery. Frailty assessments show 83% prevalence among elderly leg-ulcer patients, underscoring technology needs that address complex comorbidities. Advanced monitoring solutions that adapt to individual healing trajectories are therefore gaining clinical traction.

Rising surgical procedure volumes

Higher surgical throughput has multiplied demand for both prophylactic and therapeutic wound solutions. Closed-incision negative-pressure therapy cut infection rates to 24% from 51% in complex abdominal repairs. In femoral endarterectomy, single-use NPWT lowered complication incidence from 50.8% to 8% while reducing average costs per patient by EUR 588. Burns in patients over 85 years carry a 23.8% mortality rate, pushing hospitals to adopt specialized dressings that accelerate re-epithelialization. As value-based reimbursement gains ground, hospitals increasingly view surgical-wound performance as a determinant of financial health.

High total treatment cost for advanced modalities

Although NPWT accelerates closure, its initial device cost of EUR 2,035 per patient exceeds the EUR 1,919 outlay for conventional care, pressuring hospital budgets. Dutch basic-insurance reimbursement demands rigorous cost-effectiveness evidence before new modalities are listed, slowing adoption for premium innovations. Rising monthly insurance premiums have heightened public scrutiny of medical-device expenditures, leading payers to prioritize solutions with proven economic returns. Outpatient wound-clinic studies indicating EUR 2,621 annual savings per patient therefore focus on care-setting optimization rather than higher-priced technology upgrades.

Other drivers and restraints analyzed in the detailed report include:

• Rapidly expanding ageing population
• Uptake of negative-pressure & smart-sensor wound-therapy devices
• Stringent reimbursement approval in Dutch basic-insurance system

Segment Analysis

Wound care devices retained 67.02% share of the Netherlands wound care management devices market in 2025, led by foam dressings, hydrofibers, and negative-pressure platforms that provide superior exudate management and infection control. Smith+Nephew’s NPWT line contributed to 3.8% underlying revenue growth in its Advanced Wound Management division during Q1 2025. Clinical studies that position advanced dressings as cost-neutral over an episode of care are sustaining hospital demand even amid reimbursement scrutiny. Wound closure products account for smaller revenue but are expanding at 5.11% CAGR as staplers, sealants, and bioabsorbable clips gain favor in minimally invasive surgery. Sensor-integrated dressings that transmit temperature or pH data to clinicians are blurring category boundaries, enabling hybrid products that both close and monitor wounds.

The Netherlands wound care management devices market size for wound closure solutions is set to climb as procedure volumes rise and surgeons seek devices that limit operative time while improving cosmetic results. Incorporation of antimicrobial coatings into sutures is lowering post-operative infection risk, aligning with hospital quality metrics. Biodegradable adhesives promise avoidance of removal procedures, adding patient convenience. In parallel, developers are embedding microelectronics into adhesives to create intelligent closures capable of reporting tension or moisture in real time, a capability valued by surgical teams pursuing enhanced recovery protocols.

Chronic wounds captured 60.42% of Netherlands wound care management devices market share in 2025, reflecting the cumulative effects of aging, vascular disease, and diabetes. Prevalence of pressure ulcers in institutionalized elderly patients drives perpetual consumption of foam and antimicrobial dressings, while NPWT shortens closure timelines for recalcitrant diabetic ulcers. Frailty assessments reveal higher-than-expected care complexity, necessitating technologies that simplify dressing changes and enable caregivers with limited wound expertise. The Netherlands wound care management devices market size for chronic wounds is projected to grow steadily as the population aged 65 + rises and comorbid conditions accumulate.

Acute wounds are forecast to expand faster at 5.55% CAGR, riding on surgical volume growth and improved trauma survival rates. Prophylactic NPWT has demonstrated infection reductions of more than 50% in complex abdominal procedures, encouraging routine use in high-risk surgeries. Burns treatment for older adults remains resource-intensive, reinforcing demand for dressings that speed re-epithelialization while minimizing pain. The Netherlands wound care management devices industry increasingly couples acute-wound therapies with digital monitoring, allowing early intervention when complications emerge.

Complete Report Scope:

• By Product
  • Wound Care
    • Dressings
      • Traditional Gauze & Tape Dressings
      • Advanced Dressings
    • Wound-Care Devices
      • Negative Pressure Wound Therapy (NPWT)
      • Oxygen & Hyperbaric Systems
      • Electrical Stimulation Devices
      • Other Wound Care Devices
    • Other Wound Care Products
  • Wound Closure
    • Sutures
    • Surgical Staplers
    • Tissue Adhesives, Strips, Sealants & Glues
• By Wound Type
  • Chronic Wounds
    • Diabetic Foot Ulcer
    • Pressure Ulcer
    • Venous Leg Ulcer
    • Other Chronic Wounds
  • Acute Wounds
    • Surgical/Traumatic Wounds
    • Burns
    • Other Acute Wounds
• By End User
  • Hospitals & Specialty Wound Clinics
  • Long-term Care Facilities
  • Home-Healthcare Settings
• By Mode of Purchase
  • Institutional Procurement
  • Retail / OTC Channel

List of Companies Covered in this Report:

• Solventum
• Smiths Group
• Molnlycke Health Care
• B. Braun
• ConvaTec Group plc
• Johnson & Johnson
• Medtronic
• Lohmann & Rauscher GmbH
• Hollister
• Integra LifeSciences
• Hartmann Group
• Coloplast
• Cardinal Health
• Urgo Medical
• Medela
• Essity (BSN medical)
• Organogenesis
• Stryker
• DermaRite Industries
• MiMedx Group
• DeRoyal Industries
• Bioventus
• Kerecis Ehf.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support